We are live on ! Find out more
NRC icon

NRC Health Common Stock

74 hedge funds and large institutions have $192M invested in NRC Health Common Stock in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 31 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 19

0.38% more ownership

Funds ownership: 30.92%31.3% (+0.38%)

10% less funds holding

Funds holding: 8274 (-8)

20% less capital invested

Capital invested by funds: $242M → $192M (-$49.3M)

73% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 11

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
74
Holders Change
-8
Holders Change %
-9.76%
% of All Funds
1.7%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
3
Increased
31
Reduced
19
Closed
11
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Kayne Anderson Rudnick Investment Management
1
Kayne Anderson Rudnick Investment Management
California
$67.4M +$4.04M +120,466 +6%
Dimensional Fund Advisors
2
Dimensional Fund Advisors
Texas
$18.5M +$317K +9,445 +2%
BlackRock
3
BlackRock
New York
$13.9M -$81.5K -2,428 -0.5%
CCA
4
Conestoga Capital Advisors
Pennsylvania
$11.5M -$2.04M -60,845 -13%
Renaissance Technologies
5
Renaissance Technologies
New York
$10.1M +$1.91M +56,900 +20%
Vanguard Group
6
Vanguard Group
Pennsylvania
$9.53M +$271K +8,080 +3%
SC
7
Spitfire Capital
California
$8.8M
RA
8
Royce & Associates
New York
$6.58M +$335 +10 +0%
State Street
9
State Street
Massachusetts
$4.99M +$90.1K +2,685 +2%
Northern Trust
10
Northern Trust
Illinois
$4.28M +$100K +2,991 +2%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$2.86M +$171K +5,111 +6%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$2.79M -$35.7K -1,063 -1%
WA
13
Wasatch Advisors
Utah
$2.14M
WCM Investment Management
14
WCM Investment Management
California
$2.13M -$33.9K -1,011 -1%
Comerica Bank
15
Comerica Bank
Texas
$1.97M -$290K -8,656 -13%
Ameriprise
16
Ameriprise
Minnesota
$1.51M
WIC
17
Willis Investment Counsel
Georgia
$1.47M +$682K +20,340 +68%
Morgan Stanley
18
Morgan Stanley
New York
$1.42M +$228K +6,786 +16%
Charles Schwab
19
Charles Schwab
California
$1.27M +$43.2K +1,287 +3%
CIA
20
Capital Impact Advisors
Massachusetts
$1.21M +$182K +5,411 +15%
Bessemer Group
21
Bessemer Group
New Jersey
$1.21M
Stifel Financial
22
Stifel Financial
Missouri
$1.19M +$1.36M +40,500 New
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$1.18M -$114K -3,390 -8%
Invesco
24
Invesco
Georgia
$1.08M +$1.05M +31,381 +549%
OSAM
25
O'Shaughnessy Asset Management
Connecticut
$1.05M -$58.1K -1,733 -5%

NRC Hedge Fund Activity: Q1 2018 in Review

74 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in NRC Health Common Stock (NRC) for Q1 2018, worth a combined $192M — down 20% from $242M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of NRC and 3 opened new positions — a net loss of 8 holders — while 19 trimmed existing stakes and 31 added.

The largest buyer was Kayne Anderson Rudnick Investment Management, adding an estimated $4.04M. The largest seller was Conestoga Capital Advisors, cutting an estimated $2.04M.

  • 74 institutional investors held NRC Health Common Stock (NRC) as of Q1 2018, down from 82 in Q4 2017.
  • Funds reported $192M of NRC Health Common Stock stock for Q1 2018, down 20% quarter-over-quarter.
  • 3 funds opened new NRC Health Common Stock positions in Q1 2018 and 11 closed out, a net change of -8 holders.
  • The largest NRC Health Common Stock buyer in Q1 2018 was Kayne Anderson Rudnick Investment Management, an estimated $4.04M added.
  • The largest NRC Health Common Stock seller in Q1 2018 was Conestoga Capital Advisors, an estimated $2.04M sold.

Based on aggregated 13F filings for Q1 2018.